| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.027 | 0.8 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |